Cliffs Natural Resources Inc. (NYSE:CLF) is shedding its Canadian operations, selling U.S. coal mines and looking to get out of iron mining in Australia. On Thursday shares of Cliffs Natural Resources Inc. (NYSE:CLF) closed at $8.72. Company’s sales growth for last 5 years was 9.50% and EPS growth for next 5 years is recorded as 5.00%.
Bank of America Corporation (NYSE:BAC) reported Q4 EPS of $0.25, which may not compare with the analyst estimate of $0.32. Revenue for the quarter came in at $19.58 billion versus the consensus estimate of $21.33 billion. EPS includes about 7 cents of negative charges. Bank of America Corporation (NYSE:BAC) in last trading activity decreased -5.24% to close at $15.20. Company weekly performance is -12.09% while its quarterly performance stands at -3.25%. Bank of America Corporation (NYSE:BAC) is -16.53% away from its 52 week high.
On Jan 9, Zacks Investment Research upgraded Navigators Group Inc. (NASDAQ:NAVG) by a notchto a Zacks Rank #1 (Strong Buy) from a Zacks Rank #2 (Buy). On last trading day Navigators Group Inc. (NASDAQ:NAVG) decreased -1.18% to close at $68.39. Its volatility for the week is 2.73% while volatility for the month is 2.16%. NAVG’s sales growth for past 5 years was 5.00% and its EPS growth for past 5 years was 7.80%. Navigators Group Inc. (NASDAQ:NAVG) monthly performance is -3.29%.
Travelzoo Asia Pacific, a licensee of Travelzoo Inc. (NASDAQ:TZOO), a global Internet media company, announced their annual member survey results that showed Japan remaining the top Mainland Chinese destination in 2015 for the second consecutive year. While 40 percent of participating Mainland Chinese members chose Japan, the United States, with 31 percent votes, was their second favourite destination. The new visa agreement between China and the United States is expected to heighten Mainland Chinese interest in U.S.-based holidays. Travelzoo Inc. (NASDAQ:TZOO) has 52.32% insider ownership while its institutional ownership stands at 28.90%. In last trading activity company’s stock closed at $10.54.
Dipexium Pharmaceuticals, Inc. (NASDAQ: DPRX), a late stage pharmaceutical company focused on the development and commercialization of Locilex® (pexiganan cream 0.8%), a novel, broad spectrum, topical antibiotic peptide, announced that David P. Luci, President & Chief Executive Officer, will be presenting at the Biotech Showcase™ 2015 Conference being held in San Francisco, California. On last trading day Dipexium Pharmaceuticals, Inc. (NASDAQ:DPRX) decreased -3.25% to close at $12.49. Its volatility for the week is 6.46% while volatility for the month is 5.70%. Dipexium Pharmaceuticals, Inc. (NASDAQ:DPRX) monthly performance is 9.18%.